<DOC>
	<DOCNO>NCT02041819</DOCNO>
	<brief_summary>Nimotuzumab , humanize monoclonal antibody epidermal growth factor receptor ( EGFR ) , show effective safe study head-neck cancers.Nab-paclitaxel regimen advance NSCLC well tumor response rate safety solvent-based paclitaxel.However , safety efficacy Nimotuzumab plus nab-paclitaxel regimen uncertain neoadjuvant therapy esophageal cancer.The investigator initiate phase II clinical trial Nimotuzumab plus Nab-paclitaxel/cisplatin neoadjuvant chemotherapy patient locally advanced esophageal squamous cell carcinoma observe efficacy safety combination .</brief_summary>
	<brief_title>Neoadjuvant Chemotherapy Nimotuzumab Plus Nab-Paclitaxel Squamous Cell Carcinoma Esophagus</brief_title>
	<detailed_description>In past decade , clinical trial evaluate role neoadjuvant chemotherapy , radiation , , patient surgically resectable esophageal carcinoma , fail demonstrate consistent survival benefit . In Eastern country , preoperative chemotherapy follow radical surgery become one treatment strategy resectable , clinical stage II III esophageal cancer . In effort improve efficacy systemic chemotherapy , conduct prospective study evaluate regimen Nimotuzumab plus Nab-paclitaxel/cisplatin perioperative therapy patient resectable esophageal squamous cell carcinoma .</detailed_description>
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma , Squamous Cell</mesh_term>
	<mesh_term>Esophageal Neoplasms</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Albumin-Bound Paclitaxel</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<criteria>Histologically confirm squamous cell carcinoma thoracic esophagus , include gastroesophageal junction ( Siewert type I ) Locally advanced disease technically operable curative intent ( R0 ) T3 , N0 OR T13 , N+ OR T4 , Nx No T12 , N0 No inoperable T4 ( unequivocal organ involvement ) No distant metastasis , include M1a lymph node status Lymph nod suspicious M1a status CT scan , PET scan , ultrasound must verify fineneedle aspiration cytology No carcinoma cervical esophagus Obstructive tumor allow Not suitable surgery cervical Esophageal Carcinoma ( distance incisor tooth &lt; 19cm ) early Esophageal Carcinoma ( Stage I ) complete esophageal obstructionï¼ŒEsophageal perforation hematemesis malignant tumor , except skin basal cell carcinoma , cervical carcinoma situ pregnant breastfeeding woman people birthperiod refused take contraceptive Uncontrolled seizure psychiatric disease , loss control behavior History serious allergic castor oil allergy Patients suitable participate trial accord researcher</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>Neoadjuvant chemotherapy</keyword>
	<keyword>Nimotuzumab</keyword>
	<keyword>Nab-Paclitaxel</keyword>
	<keyword>Carcinoma Esophagus</keyword>
</DOC>